Both in Pharmaceuticals
Biomea Fusion vs Gain Therapeutics
Over the past year BMEA returned −50.0% and GANX returned −38.6%; their daily moves had a correlation of 0.21.
BMEA −50.0% GANX −38.6%Growth of $1, one year, split-adjusted
| Metric | BMEA | GANX |
|---|---|---|
| Price | $0.6599 | $1.13 |
| Market cap | $47.8M | $49.3M |
| Today | +3.19% | 0.00% |
| 1 month | −48.0% | −33.9% |
| 6 months | −55.4% | −40.5% |
| Year to date | −46.8% | −64.9% |
| 1 year | −50.4% | −35.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $34.8M | $12.7M |
| Dividend yield | — | — |
| Volatility (60d) | 121.8% | 64.1% |
| Short % of float | 24.1% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).